需要加强强迫流离失所者 (FDP) 之间的抗菌素耐药性监测
Sodiq Inaolaji Yusuff1, Yusuf Amuda Tajudeen2,3, Iyiola Olatunji Oladunjoye2
1Department of Medicine, Faculty of Clinical Sciences, Obafemi Awolowo University, Ibadan-Ife Rd, Ife, 220101, Osun State, Nigeria.
Tropical diseases, travel medicine and vaccines
|August 31, 2023
概括
抗菌素耐药性 (AMR) 是一个日益严重的全球健康危机. 加强难民人口的监测对于控制AMR传播和为公共卫生政策提供信息至关重要.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 全球卫生安全 全球卫生安全
背景情况:
- 抗菌素耐药性 (AMR) 在2019年导致495万死亡,预计到2050年将达到1000万.
- 全球抗菌耐药性监测不足,特别是在强迫流离失所者 (FDP) 方面.
- 流离失所者面临着由于生活条件恶劣和获得医疗保健的机会有限而增加的抗菌耐药性风险.
研究的目的:
- 为了突出越来越多的AMR负担在FDPs.
- 确定FDP群体内AMR监测中的差距.
- 提出建议,加强抗菌素耐药性控制和预防.
主要方法:
- 审查关于AMR和FDPs的现有文献.
- 对流离失所人口中AMR导致的因素的分析.
- 识别监控挑战和局限性.
主要成果:
- 由于特定的脆弱性,FDP受到AMR的不成比例影响.
- 目前的反抗药物耐药性监测系统存在重大缺陷.
- 基础设施和训练有素的人员不足,阻碍了有效的监督.
结论:
- 加强FDPs之间的AMR监测对于有效控制至关重要.
- 基于证据的政策需要从弱势群体获得更好的数据.
- 需要有针对性的干预措施,以减轻难民环境中的抗药性.
更多相关视频
相关概念视频
Development of Antibiotic Resistance
38
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
38
Principles of Disease Surveillance
122
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
122
Healthcare Associated Infections II: Preventive Measures
2.7K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.7K
Infection
8.1K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
8.1K
Antibiotic Selection
54.7K
Overview
54.7K
Pharmacovigilance
886
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
886


